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1 CALCIUM-SENSING RECEPTOR GENE MUTATIONS
IN SPINK1 GENE-RELATED CHRONIC PANCREATITIS
Felderbauer P, Bulut K, Ansorge N, Schmitz F, Schmidt WE,
Medizinische Klinik I, Univ.-Klinik St Josef-Hospital, Klinikum
der Ruhr-Universita¨t Bochum, Bochum, Germany
INTRODUCTION AND AIM: In the last decade the PRSS1,
CFTR and SPINK1 genes were identified to be related with chronic
pancreatitis (CP). While mutations in the PRSS1 gene have been
shown to be associated with CP, the link between SPINK1 mutations
and CP is less well defined. Hypercalcemia is also an acknowledged
risk factor for pancreatitis. Familial hypocalciuric hypercalcemia
(FHH) is a disorder that is characterized by hypercalcemia and
decreased urinary calcium exrecretion caused by inactivating muta-
tions in the calcium-sensing receptor (CaR). We have characterized
a family with FHH and CP with a novel calcium-sensing receptor
gene (CASR) mutation (L173P) and SPINK1 gene mutation, so
we sought to investigate whether mutations in the CASR gene are
associated with idiopathic chronic pancreatitis (ICP). PATIENTS
AND METHODS: A cohort of 170 patients with ICP was screened
for mutations within the CASR gene. 119 patients had a mutation
(N34S) within the SPINK1 gene and 70 among those were suffering
from CP. The entire CASR gene was screened for single-strand
conformation polymorphism under varying polyacrylamide gel
conditions and subjected to direct dideoxy nucleotide sequencing
of amplified cDNA. RESULTS: Single-strand conformation poly-
morphisms were observed in 25 patients, clustering of exons 3, 4
and 7. DNA sequence analysis revealed an as yet unreported mis-
sense mutation in exon 7 (R896H) and two conservative mutations
in exon 4 (F391F) and exon 7 (E790E). Furthermore, an intronic
polymorphism in nucleotide position 493-19 G4A was detected
in 19 of 170 patients. CONCLUSION: We identified three novel
calcium-sensing receptor gene mutations (one missense mutation,
two silent mutations and one intronic polymorphism) in a cohort
of 170 patients with ICP. Particularly the family with the R896H
mutation may indicate a role of CASR gene mutations in SPINK1
related chronic pancreatitis. Only the patient with the combination
of both, a CASR and a N34S SPINK1 gene mutation, developed
pancreatitis, whereas in the healthy parents and children either a
CASR or a N34S SPINK1 gene mutation could be detected. Future
studies will have to address whether calcium-sensing receptor gene
mutations represent a predisposing factor for SPINK1-related
chronic pancreatitis.
2 PROTEOMICS IN AUTOIMMUNE PANCREATITIS:
LACK OF PROTEASES AND PANCREATIC
STONE PROTEIN
Faissner R3, Wandschneider S1, Kozcan D2, Funk A3, Frulloni L4,
Zamboni G5, Bassi C4, Klo¨ppel G6, Lo¨hr JM3, (1) Central Protein
Analysis, DKFZ, Heidelberg, Germany; (2) Institute of
Immunology and Proteome Center, University of Rostock,
Rostock, Germany; (3) 2nd Medical Faculty Mannheim,
University of Heidelberg, Mannheim, Germany; (4) Department
of Surgical and Gastroenterological Sciences, University of Verona,
Verona, Italy; (5) Department of Pathology, University of Verona,
Verona, Italy; (6) Department of Pathology, University of Kiel,
Kiel, Germany
INTRODUCTION AND AIM: Autoimmune pancreatitis rep-
resents a recently identified disease of the pancreas with unknown
etiology and antigens. The aim was to determine new target antigens
and differentially regulated proteins with proteomics. PATIENTS
AND METHODS: Protein extractions were made from fresh-frozen
tissue of healthy controls, chronic pancreatitis and autoimmune
pancreatitis patients using different buffer systems (Tris, CHAPS).
High-resolution 2-D gels were produced (IEF, SDS-PAGE) and
the resulting gels were stained and digitalized. Image analysis was
performed (PDQuest) and differentially regulated proteins were
excised from the gel, digested, and submitted to mass spectrometry
(MALDI-TOF-MS: Bruker Reflex III). Profiles from peptide spectra
were run against the database (e.g. Mascot). RESULTS: More than
120 protein spots have been identified to date. There was an exclusive
down-regulation of pancreatic proteases trypsinogen (trypsinogen-1;
trypsinogen-2, mesotrypsinogen) and pancreatic stone protein (PSP)
in autoimmune pancreatitis in comparison to both chronic pan-
creatitis and healthy controls. In contrast, transthyretin, cathepsin D
and PDGF were exclusively expressed in autoimmune pancreatitis
but not in chronic pancreatitis and healthy controls. Several other
proteins were expressed in the same direction in both chronic and
autoimmune pancreatitis. CONCLUSION: The lack of PSP as a
stress protein and TGF (as shown by others) may account for the
lack of fibrosis and the overwhelming inflammatory infiltrate. The
meaning of the lacking proteases remains to be elucidated.
3 SUBSTANCE P MRNA EXPRESSION IN PANCREATIC
TISSUE CORRELATES WITH SUBSTANCE P SERUM
LEVELS IN PATIENTS WITH CHRONIC PANCREATITIS
Mascetta G1, Selvaggi F1, Di Mola FF2, Falconi M3, Bassi C3,
Pederzoli P4, Giese N2, Friess H2, Bu¨chler MW2, Di Sebastiano P2,
(1) Surgical Department, University of Chieti, Chieti, Italy; (2)
General and Transplantation Surgery, University of Heidelberg,
Heidelberg, Germany; (3) Surgical Department, University of
Verona, Verona, Italy; (4) General Surgery, University of Verona,
Verona, Italy
INTRODUCTION AND AIM: Pain is the leading symptom in
chronic pancreatitis (CP) and often surgical management is neces-
sary in cases with medically intractable pain. The pathophysiology
of pain in CP is still incompletely understood. Recent data suggest
a role for neuropeptides, such as substance P (SP), and the neuro-
immune interaction in the inflammatory process of the pancreas. SP
is involved in pain transmission and we have already demonstrated an
increased expression of this neuropeptide in CP; however, no data
are available about the possible correlation between tissue and serum
levels.The aim was to investigate a possible correlation between
SP mRNA expression in pancreatic tissue and serum levels of SP
in patients undergoing surgical procedures because of chronic
pancreatitis to confirm the hypothesis of neuroimmune inflammation
as pathogenetic factor in CP. PATIENTS AND METHODS: SP
mRNA levels were analysed by quantitative RT-PCR in pancreatic
tissue specimens from 30 patients with CP undergoing pancreatic
resection and 10 healthy organ donors. In addition, SP serum levels
were determined before surgical procedure by using enzyme
immunoassay (ELISA). RESULTS: Quantitative RT-PCR demon-
strated increased SP mRNA expression in CP tissues (p50.05).
Before undergoing a surgical procedure patients with CP exhibited
significantly higher SP serum levels in comparison with control
group. CONCLUSION: The present data confirm an increase of SP
expression during chronic inflammation of the pancreas. Further-
more, the SP mRNA tissue expression correlates with increased
serum levels in CP patients. SP acting essentially as a proinflam-
matory neuropeptide seems to be not only localized in the inflamed
pancreas but also influences the systemic environment, as suggested
by our findings. As already demonstrated in other chronic inflam-
matory conditions, SP might also represent a reliable marker of
neurogenic inflammation in CP patients. The long-term post-
operative control of SP serum levels will be the object of further
studies.
4 DIAGNOSTIC VALUE OF MULTI DETECTOR CT
AND MRCP IN ADVANCED SYMPTOMATIC
CHRONIC PANCREATITIS
Nio CY2, Cahen DL1, Stoker J2, Bruno MJ1, Phoa SSKS2,
Gouma DJ3, Lameris JS2, (1) Gastroenterology; (2) Radiology;
(3) Surgery, Academic Medical Center/Amsterdam, Amsterdam,
Netherlands
INTRODUCTION AND AIM: The purpose was to assess
the diagnostic value of contrast-enhanced multi detector CT and
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magnetic resonance cholangio-pancreaticography (MRCP) for
detection of pancreatic duct (PD) stones, PD dilatation and PD
stenosis in patients with advanced symptomatic chronic pancreatitis.
PATIENTS AND METHODS: 4 patients (26/18 m/f; median
age 53, range 24–80) with symptomatic chronic pancreatitis were
prospectively included in this study. CT was performed with 1.3-mm
effective slice thickness after 130 ml i.v. contrast (3.5 ml/s, delay
50 s) (Philips MX 8000). On the same day MRCP at 1.5 T
(Siemens Vision) was performed, including thick slab (40-mm) and
thin slices (3-mm) HASTE MRCP (before and after secretin
stimulation) and VIBE after gadolinium iv. Two blinded gastro-
intestinal radiologists read the CT or MRCP separately at a work-
station. After 6 months both radiologists switched modalities,
making it possible to perform an inter-observer analysis using
kappa-statistics. PD was scored for dilatation, stenosis and intra-
ductal stones. Furthermore peripancreatic infiltration and paren-
chymal calcifications were evaluated. Findings were correlated with
either endoscopic retrograde cholangio-pancreaticography (ERCP),
endoscopic ultrasonography or findings at surgery. RESULTS:
Sensitivity for intraductal stones was 0.98 (CT) and 0.70 (MR)
(p50.05); specificity was 0.83 (CT) and 0.79 (MR). Sensitivity for
PD dilatation was 0.92 (CT) and 0.90 (MR). Sensitivity for PD
stenosis was 0.27 (CT) and 0.34 (MR). Parenchymal calcifications
and peripancreatic infiltration were most prominent on CT. In
CT-positive cases, these findings were detected by MR in only 26%
and 31% of cases, respectively. The inter-observer agreement
was very good for intraductal stones on CT (0.94) and moderate
for MR (0.45). For the other parameters the agreement varied
for CT between 0.66 and 0.90 and for MR between 0 to 0.63.
CONCLUSION: CT is superior to MR in the detection of pan-
creatic ductal stones and visualizes more parenchymal calcifications
and peripancreatic infiltration. For ductal dilatation and stenosis
both modalities yield comparable results. CT is therefore the
preferred imaging modality in advanced symptomatic chronic
pancreatitis.
5 PHOSPHATIDYLSERINE RECEPTOR EXPRESSION
DOES NOT CORRELATE WITH APOPTOSIS IN
CHRONIC PANCREATITIS
Balaz P, Hospital Freital, Department of Surgery, Freital,
Germany
INTRODUCTION AND AIM: The phosphatidylserine receptor
(PSR) was found to be expressed on the surface of macrophages
and was suggested to be crucial for the recognition and engulf-
ment of apoptotic cells. In chronic pancreatitis, destruction of
parenchyma is accompanied by infiltration of lymphocytes and
macrophages. In the present study we proved the PSR expression
and its relation to apoptosis in chronic pancreatitis. PATIENTS
AND METHODS: The expression of PSR was analyzed by
Northern blot analysis, Western blot analysis and immuno-
histochemistry. Apoptosis in chronic pancreatitis tissue samples
was detected by the TUNEL method, and the RNA protection
assay (RPA) was used to compare activation of apoptosis with PSR
mRNA expression levels. In addition, the molecular data were
related to clinicopathological parameters. RESULTS: PSR mRNA
expression was low to absent in normal pancreatic tissue samples.
In human chronic pancreatitis, increased expression of PSR
mRNA was present in 12 of 29 samples (41%, p50.001). The
PSR cytoplasmatic immunoreactivity was present in all islets, in
some ductal cells and only rarely in macrophages. The RNA
protection assay revealed high mRNA levels of the anti-apoptotic
genes bcl-2 and bfl-1 (p50.05) in chronic pancreatitis tissues
with high PSR mRNA expression. Their expression levels correlate
with high PSR mRNA expression levels (p50.05). The TUNEL
apoptosis in situ detection method showed positive signals in some
acinar cells and focally in acinar cells adjacent to stromal fibro-
blasts in chronic pancreatitis tissue samples. The distribution
pattern of PSR in chronic pancreatitis did not correspond with
regions of apoptotic activity. CONCLUSION: We showed for the
first time the presence of PSR expression in human chronic
pancreatitis cells and in islet cells but not only in macrophages as
expected. PSR expression and localization does not correlate with
apoptotic cells regions and proapoptotic gene expression in chronic
pancreatitis.
6 VITAMIN C, SELENIUM AND GLUTATHIONE
LEVELS BEFORE AND AFTER MAIN PANCREATIC DUCT
DECOMPRESSION SURGERY
Jamdar S, Siriwardana A, Al-Rashedy M, HPB Unit,
Department of Surgery, Manchester Royal Infirmary,
Manchester, UK
INTRODUCTION AND AIM: Oxidative stress is associated
with anti-oxidant depletion in chronic pancreatitis (CP). Relief of
pancreatic ductal (PD) hypertension can relieve symptoms in
some patients. This study tests the hypothesis that duct decom-
pression surgery leads to normalization of anti-oxidant levels and
that this may be a marker of pancreatic healing. PATIENTS AND
METHODS: Patients underwent pancreatic duct drainage surgery
for CP in a regional hepatobiliary centre from October 1999 to
June 2001. Surgery was offered if the following criteria were met:
opiate-dependent pain, avoidance of alcohol plus PD dilatation
(41 cm) with portal patency. Five patients fulfilled the criteria and
underwent Frey lateral pancreaticojejunostomy. Anti-oxidants were
assayed before surgery and at the point of most recent follow-up.
Follow-up assessed pain scores (visual analogue scale – VAS) and
opiate use. Data are presented as median (range). Wilcoxon’s
test was used for matched pairs. RESULTS: There were no peri-
operative deaths. Median follow-up was 57 (41–61) months. Pre-
operative VAS scores were 10 in all. Postoperative scores were 0
(0–5, p=0.06). None are presently on opiates. Preoperative anti-
oxidant levels were: vitamin C, 5.8 (2.9–20.5) mg/ml, selenium-139.5
(79–221) microg/l; whole blood glutathione, 11.61 (10.50–12.51)
mmol/gHb and plasma glutathione, 1526 (1339–1544) mmol/l.
Postoperative levels were: vitamin C, 9.3 (6.5–15.2), selenium, 67
(62–96), whole blood glutathione, 10.99 (10.45–13.10), and plasma
glutathione, 1505 (1366–1670). There was no statistically significant
difference between preoperative and postoperative levels (p40.05).
CONCLUSION: This is the first report of the effect of PD decom-
pression surgery on anti-oxidant levels in CP. The results do
not suggest that duct decompression is associated with a change in
anti-oxidant levels.
7 TUBERCULOSIS INFECTION DURING CHRONIC
PANCREATITIS: INCIDENCE AND RISK FACTORS
Barbu ST, Oniu T, Cazacu M, IVth Surgical Clinic, University of
Medicine and Pharmacy Iuliu Hatieganu ‘Cluj-Napoca, Romania’,
Cluj-Napoca, Romania
INTRODUCTION AND AIM: Tuberculosis is a major threat in
Romania (incidence more than 10 times that of western countries).
Tuberculosis infection occurring during chronic pancreatitis (CP)
jeopardizes the life of the malnourished, debilitated patients. The
aim was to assess the incidence and identify risk factors for tuber-
culosis in patients with CP. PATIENTS AND METHODS:
We performed a retrospective record analysis (10.6 years average
duration of CP) and a subsequent prospective follow-up
(mean=6.3 years) of 105 CP patients from the Transylvania region
operated in our clinic (1991–2000). To find risk factors for tuber-
culosis, we applied a Pearson product-moment correlation test, and
multiple regression analysis for the following factors: age, sex,
geographic distribution, profession, alcohol intake, cigarette smok-
ing (number of cigarettes and years of smoking), CP duration,
presence of calcifications, diabetes, steatorrhea, number of CP
complications, BMI, and contact with infectious tuberculosis.
RESULTS: During the follow-up period, 7 patients (6.66%)
developed pulmonary tuberculosis. Six patients had severe forms (3
bilateral multiple cavities, 2 miliary form, and 1 pulmonary and
peritoneal tuberculosis). Significant risk factors for tuberculosis
(p50.005) were: high alcohol consumption, heavy smoking (420
cigarettes/day), presence of diabetes, advanced CP (calcifications,
steatorrhea, malnutrition with BMI518), contact with infectious
tuberculosis, and immunodepression. CONCLUSION: Tubercu-
losis infection (mostly severe forms), have a higher incidence in
patients with CP (especially in those with advanced disease) than in
the general population. Prevention of tuberculosis implies quitting
smoking and alcohol consumption, and better control of diabetes
and steatorrhea. Follow-up of high risk patients must include
screening for tuberculosis.
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8 THE CLINICAL COURSE OF CHRONIC PANCREATITIS
ASSOCIATED WITH HYPERLIPEMIA IN CHILDREN
Oracz G, Oralewska B, Teisseyre M, Ryzko J, Socha J,
Department of Gastroenterology, Hepatology and Immunology,
Children’s Memorial Health Institute, Warsaw, Poland
INTRODUCTION AND AIM: The reported pediatric experience
with chronic pancreatitis (CP) is small and the role of hyperlipemia is
not well elucidated. The aim of this study was to evaluate the role
of hyperlipemia as a cause of CP in children. PATIENTS AND
METHODS: 97 children with CP, hospitalized from 1995 to 2004,
were enrolled into the study. Medical records of these patients were
reviewed for data on the presentation, diagnostic findings and
endoscopic treatment. RESULTS: Hyperlipemia was found in 19
patients (19.6%) (14 girls and 5 boys; mean age 11.5 years, range:
3.6–17.8 years). We detected hypertriglyceridemia in 8 patients,
hypercholesterolemia in 11 patients. In 5 patients with hyperlipemia
we found gene mutations (CFTR-deltaF508/-; PRSS1-R122C/-;
AAT-E34K/- in one patient and in 2 patients SPINK1-N34S/-);
anatomic anomalies of pancreatic duct were found in 3 patients.
7 patients were obese (Cole index4120%). There was no difference
in age of disease onset between hyperlipemia (HA group) and
non-hyperlipemia group (NHA group) (9.6 years vs 8.7 years, NS).
In all children ERCP had evidence of CP (8 mild, 5 moderate and
6 severe, according to the Cambridge Classification System, mean
1.9o Cambridge grade vs 1.95o in NHA group, NS). Therapeutic
intervention, including both surgical and endoscopic inter-
vention, was more frequent in the HA group (63% vs 54.5%; NS).
CONCLUSION: 1. CP associated with hyperlipemia is common
in children and has a similar clinical course to CP in the NHA group.
2. We should be aware of coexisting hyperlipemia and other factors
causing CP, such as gene mutations.
9 PANCREATIC PSEUDOCYSTS: EFFECTIVENESS
OF ENDOSCOPIC DRAINAGE PROCEDURES
Zdanyte E, Strupas K, Uzkalnis A, Sileikis A, Jurevicius S, Center
of Abdominal Surgery, Vilnius University, Vilnius, Lithuania
INTRODUCTION AND AIM: Indications and contraindications
for endoscopic drainage of pancreatic pseudocysts are still under
discussion. The purpose of our study was to evaluate the effectiveness
of endoscopic drainage procedures and to establish selection criteria
for this procedure. PATIENTS AND METHODS: 34 patients
(mean age 46.6, range 20–87 years) with 35 pancreatic pseudocysts
were managed by the endoscopic route from February 2000 to
December 2004. The pseudocysts were located in the head/neck
of the pancreas (n=8), body (n=22) and tail (n=5). The mean size
was of 11.46 cm, volume 863.96 ml and wall thickness 5.04 mm.
There were 35 endoscopic drainage procedures: 14 pseudocysto-
gastrostomies/pseudocystoduodenostomies (length range from 5
to 60 mm), 20 cases of transmural drainage with double pigtail
stent, and 1 pancreatic duct sphincterotomy. RESULTS: 28 (80%)
pseudocysts completely resolved. There were 6 bleeding episodes:
endoscopic haemostasis was achieved in 5 cases, one patient
underwent emergency operation. 6 patients required subsequent
operations because of gastric wall perforation (3), postoperative
haemorrhage (1), or insufficient drainage (2). CONCLUSION:
Endoscopic drainage is an effective alternative to surgical treatment
of pancreatic pseudocysts. It makes it possible to avoid external
fistula formation in the cases of suppurated pancreatic pseudocysts.
Bleeding is the most frequent complication of transmural drainage
and it is successfully managed by endoscopic haemostasis. Contra-
indications for this procedure are underlying pancreatic head en-
largement and/or pancreatic duct cut-off or dilation when pancreatic
resection or duct drainage operations are indicated. Resection should
always be performed in cases when diagnosis of cystic neoplasm
could not be rejected.
10 BLOOD PHYSICOCHEMICAL PROPERTIES IN
PATIENTS WITH CHRONIC PANCREATITIS (CP)
Gubergrits NB, Golubova O, Chair of Internal Diseases No. 1,
Donetsk State Medical University, Donetsk, Ukraine
INTRODUCTION AND AIM: During CP there is changing
content of proteins, lipids, carbohydrates, electrolytes and other
surface-active agents into biological fluids including blood. This
results in changes in blood physicochemical properties. The aim
was to study blood physicochemical changes in CP. PATIENTS
AND METHODS: We observed 72 patients with CP. They
underwent interphase tensiometry (tensiometer MPT-2 Lauda,
Germany) and rheometry (apparatus ADSA, Canada) of blood,
during which we determined dynamic surface tension (ST) after
t=0.01 s (ST1), t=1 s (ST2), t=100 s (ST3), t=104 S (ST4),
angle of tensiogram curve slope (ATCS), viscoelasticity (E) and time
of serum relaxation (T). These data were compared to biochemical
indices. 30 healthy persons were also examined. RESULTS: All
blood tensiogram indices (except ST2) in CP patients were reliably
different from normal levels: ST1, ATCS and T were elevated;
ST3, ST4 and E were reduced. ST1 correlated with blood lipase
activity (r=+0.62), ATCS with alpha-amylase (nu=+0.38) and
P-isoamylase (r=+0.58) activity in blood. T had negative corre-
lation with the volume of duodenal contents obtained during
probe examination (r=–0.52) and positive correlation with immuno-
reactive tripsin blood level (r=+0.74). Blood ST3 and ST4 were
connected to indices of the fecal elastase-1, E to bicarbonate debit-
part (nu=+0.58). Results of correlation analysis show the possibility
of using blood interphase tensiometry and rheometry for integral
evaluation of CP clinical course and treatment efficacy. CON-
CLUSION: Significant changes of blood physicochemical properties
develop during CP. So results of blood tensiometry and rheometry
may be used for monitoring of clinical course of the disease.
11 DIAGNOSIS AND MANAGEMENT OF BLEEDING
PSEUDOANEURYSMS COMPLICATING PANCREATITIS
Sileikis A, Strupas K, Jurevicius S, Zdanyte E, Abdominal Surgery,
Vilnius University, Vilnius, Lithuania
INTRODUCTION AND AIM: Pseudoaneurysm following
pancreatitis is a severe complication that can lead to massive
gastrointestinal bleeding and high mortality. Limited data have been
reported and no evidence-based guidelines are currently available
regarding the optimal treatment modality. The aim of this article is
to present our experience of management of bleeding pseudo-
aneurysms. PATIENTS AND METHODS: We report our experi-
ence with 11 patients with bleeding pseudoaneurysms treated over a
period of 9 years (1995–2004). RESULTS: Gastrointestinal bleed-
ing from pseudoaneurysm was suspected when endoscopic imaging
did not reveal typical bleeding source and the patient had a history
of pancreatitis. In our case all patients suffered from chronic
pancreatitis, 9 of them from pseudocysts. Endoscopic imaging of
9 revealed small atypical mucosal injures and of 2 blood issuing
from papillae duodeni majoris. These findings helped us to suspect
bleeding from pseudoaneurysms and to confirm it by angiography
or in another case by CT and ERCP. In the latter two cases
CT angiography allowed us to make the correct diagnosis without
traditional angiography. All these patients underwent surgery:
5 radical pancreas head resection, 3 distal pancreas resection, for
2 patients pseudoaneurysms of arteria lienalis were only removed and
for 1 patient subtotal pancreas head resection was performed with
ligature of pseudoaneurysm. We had two postoperative compli-
cations: pancreatic fistula, after distal pancreas resection and acute
pancreatitis following anastomosis leakage after subtotal pancreas
head resection. CONCLUSION: Bleeding from pseudoaneurysm
must be suspected when endoscopic imaging does not reveal a clear
bleeding source and the patient has a history of pancreatitis. It is
not necessary to carry out traditional angiography to confirm diag-
nosis, CT angiography is sufficient. The best choice of operation is
to remove the damaged part of the pancreas together with the
pseudoaneurysm.
12 SURGICAL VERSUS ENDOSCOPIC PROCEDURES
FOR CHRONIC PANCREATITIS
Karaliotas C, Sgourakis G, Christofidis T, Papaioannou N, Gekas C,
2nd Department of General Surgery, Red Cross Hospital, Athens,
Greece
INTRODUCTION AND AIM: We present retrospectively, the
results of 33 patients with chronic pancreatitis, treated either
endoscopically or surgically. PATIENTS AND METHODS: From
1990 to 2003, 33 patients with chronic pancreatitis were referred
to us. Ten patients were dealt with by ERCP and pancreatic duct
EHPBA European Congress Abstracts 71
endoscopic sphincterotomy (9 in the main and 1 in the accessory)
and 23 patients with pancreatectomy (excluding total) or some form
of pancreatic duct drainage procedure, taking into account the size
of the lesion. Criteria for successful outcome were weight gain and
pain relief. RESULTS: Endoscopy group: Complete pancreatic
stone retrieval was done in 6 patients, incomplete in 3 and in 1 the
procedure failed. Average follow-up was 44.6 months. Mean dura-
tion of pain relief was 37 months. Weight gain was apparent in 4.
Pain relief and reduction in the use of analgesics was accomplished
in 6. Four patients were referred for surgery. Surgery group: Average
follow-up was 46 months. Mean duration of pain relief was 52
months. Weight gain was apparent in all patients. Pain relief and
reduction in the use of analgesics was accomplished in all but 2
patients. Weight gain and pain relief in favor of the surgery group was
statistically significant at the level of p50.0433 and p50.0367,
respectively. CONCLUSION: Surgery is the gold standard in deal-
ing with chronic pancreatitis. Endoscopic pancreatic duct sphinc-
terotomy has fair results in the absence of stenosis, cysts, or more
than 3 stones in the pancreatic duct. Drainage procedures are best
applied in the presence of a dilated pancreatic duct.
13 EFFICACY OF THE HOMOTOXIC DRUG
MOMORDICA COMPOSITUM IN THE TREATMENT
OF CHRONIC PANCREATITIS (CP)
Gubergrits NB, Kolkina V, Chair of Internal Diseases No. 1,
Donetsk State Medical University, Donetsk, Ukraine
INTRODUCTION AND AIM: Experimental data indicate that
the severity of pancreatitis decreases after treatment with anti-
homotoxic preparations (B. Jankowska et al., 1998). The aim was
to study results of CP treatment with antihomotoxic preparation
Momordica compositum (Heel, Germany). PATIENTS AND
METHODS: We observed 60 patients suffering from CP. 30 of
them received traditional therapy in combination with Momordica
compositum 2.2 ml intramuscularly once in 3 days N10 (main
group). Another 30 patients received traditional therapy only
(comparison group). We studied the dynamics of the CP clinical
picture, of the functional and structural changes of pancreas during
the treatment. RESULTS: At the end of the treatment pain dis-
appeared or was minimal in 86.7% of the main group and 66.7% of
the comparison group. Hyperfermentemia was reduced significantly
due to inclusion of Momordica compositum in the treatment
scheme. Blood pancreatic isoamylase activity in patients of the main
group was reduced from 0.77+ 0.09 mccat/L to 0.47+0.08 mccat/
L (p50.05), whereas in patients in the comparison group it was
from 0.75+0.08 mccat/L to 0.61+0.10 mccat/L (p40.05) and in
the healthy it was 0.52+0.12 mccat/L. Improvement of pancreatic
excretory secretion due to treatment with Momordica compositum
was proved by higher lipase debit-part in the patients of the main
group (110860+2250 U/Lh), than in patients of the comparison
group (90140+2380 U/Lh; p50.05); in the healthy 120800+4640
U/Lh. The patients in the main group also had better results of
pancreas ultrasound histogram at the end of the treatment.
CONCLUSION: Inclusion of antihomotoxic preparation Momor-
dica compositum into complex therapy of CP helps to improve
results of the treatment.
14 RESULTS OF RESECTION AND DRAINAGE
OPERATIONS FOR CHRONIC PANCREATITIS
Shatveryan G, Skipenko OG, Frolov O, Bedzhanyan A,
Department of Liver, Bile Duct and Pancreas Surgery, Russian
National Research Center of Surgery RAMS, Moscow, Russia
INTRODUCTION AND AIM: The management of chronic
pancreatitis (CP) remains a challenging problem. The surgical
treatments of choice are proximal or distal resections of pancreas for
small-duct disease and pancreaticojejunal drainage for large-duct
disease. PATIENTS AND METHODS: Between 1990 and 2004,
167 patients underwent pancreatoduodenal resection (n=23), distal
resection (n=18) and different types of drain procedures (pancre-
atico-, cystojejunal, external). Retrospective analysis of patient data
was done. There were 138 (82.6%) male and 29 (17.4%) female,
mean age 42.9+10.9 years (range 21–73). RESULTS: Pain
was observed in 147 (88%), obstructive jaundice in 31 (18.6%),
duodenal obstruction in 8 (4.8%) and segmental portal hypertension
in 18 (10.8%) patients. 25 patients had preoperative diabetes,
exocrine insufficiency was observed in 60 (35.9%) patients. 2 patients
died within 30 days after pancreatoduodenal resection (mortality
1.2%). Postoperative morbidity after drainage procedures (group I)
was 28.7% patients, after resection (group II) 43.9%. Anastomotic
leak was observed in 4 patients in group I and in 8 patients in
group II. The frequency of pancreatic fistula was lower in group I
(3.6%) than in group II (14.6%) (p50.05). Delayed gastric emptying
occurred in 5 of 11 patients (45.4%) after duodenum-preserving
pancreatic head resection. Pain relief occurred in 81.6% patients.
New cases of diabetes after operation in both groups were not
registered. CONCLUSION: The correctly selected operation
allows provision of long-lasting pain relief. Drainage and resection
procedures for CP do not reduce endocrine function of pancreas.
15 DISTAL PANCREATECTOMY FOR CHRONIC
PANCREATITIS – RELIEF OF PAIN FOLLOWING LIMITED
RESECTION OF THE LEFT PANCREAS
Schlosser W, Henne-Bruns D, Department of Visceral and
Transplant Surgery, University of Ulm, Ulm, Germany
INTRODUCTION AND AIM: Some patients with chronic
pancreatitis (CP) develop an inflammatory tumor or pancreatic
pseudocysts in the pancreatic tail. The differentiation between
inflammatory tumor and malignant lesion might be difficult in some
cases. The spectrum of modern surgical treatment of chronic
pancreatitis includes the spleen-preserving distal pancreatectomy
with preservation of as much parenchyma as possible. We present
long-term results of patients operated with a distal pancreatectomy
for chronic pancreatitis in the pancreatic tail. PATIENTS AND
METHODS: 71 patients with CP (41 male, 30 female; median age
47 years), who were operated between January 1980 and December
2002 with a distal pancreatectomy, were evaluated prospectively.
The patients had a median medical respective pain treatment of
35 months prior to surgery. The etiology of CP was chronic alcohol
consumption in 75% of the patients. The main indications for
surgical treatment were: pain 97%, pseudocyst 53%, inflammatory
tumor 37% and suspected malignoma 15%. RESULTS: Distal
pancreatectomy was performed in all patients, the preservation of
the spleen was possible in 24 patients (34%). The operative
morbidity was 44%; however, the group of patients with splenectomy
had a significantly increased morbidity compared to patients with
preservation of the spleen (49% vs 33%). Two patients had to be
reoperated following spleen-preserving distal pancreatectomy.
Hospital mortality was 0%. The median hospitalisation was 19 days.
Follow-up: 34 patients (85%) were followed up in the outpatient
clinic with a median follow-up of 110 months (20–240 months), the
late mortality was 37%. 76% of the patients were completely free
of pain, only 2 patients suffered from severe pain further on. Body
weight increased or was unchanged in 79% of the patients. Late
postoperative endocrine function was unchanged in 74% (improved
3%, deteriorated 24%). CONCLUSION: Inflammatory tumors,
pseudocysts and suspected malignoma are the main indications
for distal pancreatectomy in chronic pancreatitis. The splenectomy
leads to a significantly elevated operative morbidity. Therefore, the
preservation of the spleen should be one of the main goals whenever
possible. The long-term results demonstrate an improved quality of
life according to significantly reduced pancreatic pain and a better
physical status compared with patients treated medically.
16 STRUCTURE OF TNF-ALPHA IN PATIENTS WITH
CHRONIC RELAPSING PANCREATITIS IN THE PRESENCE
BILIO-PANCREATIC REFLUX
Shirinskaya NV, Dolgich TI, Omsk State Medical Academy,
OKDC, Omsk, Russia
INTRODUCTION AND AIM: Examination of TNF-alpha in
patients with chronic relapse pancreatitis, depending on the presence
of bilio-pancreatic reflux. PATIENTS AND METHODS: 80
patients in remission were surveyed (42 female, 38 male; age range
39.7+4.9 years). Patients with gallstones were excluded from the
study. All patients were surveyed by a ‘Method dynamic ultra-
sonography measuring with revealing reaction for the Wirsung’s
duct on stimulation of a gallbladder’ (Certificate1 2512 on November
2002) for revealing bilio-pancreatic reflux. Presence of the regur-
gitation of bile to the Wirsung’s duct specified expansion of a gleam
Wirsung’s duct in reduction of the gallbladder. In healthy patients
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the gleam Wirsung’s duct decreased (in connection with normal
function of Oddi sphincter and absence of obstacles to outflow of
bile). RESULTS: Bilio-pancreatic reflux was revealed in 60 patients:
in 9, reaction as in healthy persons and in 11, bilio-pancreatic reflux
was blocked by sclerous of the Wirsung’s duct. The attention to
essential distinction levels of TNF-alpha on remission in patients
with chronic relapse pancreatitis, depending on presence or absence
of bilio-pancreatic reflux. Patients with bilio-pancreatic reflux have
TNF-alpha levels of 96.82+5.68 pg/ml; patients without an obser-
vable reflux have 6.82+2.19 pg/ml. CONCLUSION: The bilio-
pancreatic reflux supports high activity of inflammatory processes
in patients with chronic relapse pancreatitis on a background seen
on clinical remission; and is supported by reflux bile for the Wirsung’s
duct.
17 BEGER PROCEDURE FOR CHRONIC PANCREATITIS:
THE BRAZILIAN EXPERIENCE
Pacheco A Jr, De Campos T, Sazaqui A, Sassatani A, De Moricz A,
Rego R, Department of Surgery, Santa Casa School of Medicine,
Sa˜o Paulo, Brazil
INTRODUCTION AND AIM: Chronic pancreatitis requires
surgical treatment in about 20% of patients. Inflammatory tumor
in the head of the pancreas is considered the pacemaker in chronic
pancreatitis. The aim of this study is to evaluate the experience of
one center performing the Beger procedure for the treatment of
chronic pancreatitis (CP). PATIENTS AND METHODS: The
Beger procedure was introduced at Santa Casa School of Medicine
in Sao Paulo in November 1995. The indications for this operation
were the diagnosis of CP, associated with a mass in the head of the
pancreas, with no response to clinical treatment, and with compli-
cations such as untreatable pain, biliary obstruction or digestive
obstruction. RESULTS: We performed 17 Beger procedures in this
period. Fourteen (82.4%) patients were men. The etiology of chronic
pancreatitis was alcohol in 16 patients, and pancreas divisum in
one. The mean operation time was 7 h (varying from 6 to 10 h).
In three patients we had to change the operation to a pylorus-
preserving pancreatoduodenectomy. The main complication was
duodenal ischemia in four patients (23.5%) with need of segmental
resection and suture in one patient and duodenectomy in three.
Three patients died (17.6%) due to clinical complications in the
postoperative period. Relief of pain was achieved in 84.6% with also
weight gain in these patients. CONCLUSION: Although we had
high morbidity and mortality in our learning curve, the Beger
procedure performed by an experienced surgeon is a good option
to relieve pain in these patients.
18 IS EARLY ENTERAL NUTRITION IN SEVERE
PANCREATITIS DANGEROUS?
Eleftheria K, Antsaklis G, Alexiou K, Sakellaridis T, Karanikas I,
Department of General Surgery, Sismanoglion General Hospital,
Athens, Greece
INTRODUCTION AND AIM: Necrotizing pancreatitis may be
protracted and nutritional support is frequently required to maintain
the patient’s nutritional status. Recent works has suggested that
enteral feeding with nasojejunal tubes may reduce the magnitude
of the inflammatory response and the bacterial translocation.
PATIENTS AND METHODS: From 2000 to 2004, 18 patients
with necrotizing pancreatitis were hospitalized in our clinic.The
cause of pancreatitis was found to be gallstones in 16 patients, alcohol
in one patient and hyperlipidemia in one patient. Pancreatic necrosis
was determined by spiral CT using rapid bolus intravenous contrast
and the severity was estimated using the Balthazar score. In 15
patients a nasojejunal tube was introduced in first 48 h from
admission to the hospital and they received enteral nutrition enriched
with immuno-enhancing supplements. RESULTS: Ten patients
had developed organ failure necessitating ventilatory support. The
mortality rate was 27.7%. The enteral nutrition was well tolerated in
all 16 patients. No feeding tube or metabolic nutrition-related
complications were observed. CONCLUSION: Early enteral nutri-
tion is safe and efficacious in patients with severe pancreatitis and the
cost per patient of enteral nutrition is considerably less than that
of total parenteral nutrition.
19 CLINICO-PATHOGENETIC VARIANTS OF
CHRONIC ALCOHOLIC PANCREATITIS (CAP)
CLINICAL COURSE
Gubergrits NB, Belyayeva N, Zagorenko Y, Chair of Internal
Diseases No. 1, Donetsk State Medical University,
Donetsk, Ukraine
INTRODUCTION AND AIM: Significance of symptoms may
vary in different patients with CAP. Aim: to determine clinico-
pathogenetic variants of CAP. PATIENTS AND METHODS:
We examined 92 CAP patients. Clinical course of the disease, blood
levels of pancreatic enzymes (immunoreactive trypsin and phos-
pholipase A2, pancreatic isoamylase), direct (probe) study of
pancreatic excretory function and ultrasound histography of the
pancreas head were conducted. RESULTS: All patients were
divided into 3 groups: ‘indurative-obstructive’ CAP (44 patients),
‘parenchymatous’ CAP (40 patients) and combined variant
(8 patients). Indurative-obstructive CAP has a pain rate 1.76 times
less, grade of the clinical picture of pancreatic excretory insufficiency
1.61 times more and the incidence of diabetes mellitus 1.64 times
more than the parenchymatous variant of the disease. Significant
enzymes’ ‘deviation’ to blood phenomenon is characteristic for
parenchymatous CAP and 53.1% of all examined patients had the
upper obturative type of pancreatic secretion. Ultrasonography
revealed signs of edema, infiltration of parenchyma and involvement
of parapancreatic fat in case of parenchymatous variant. The
indurative-obstructive CAP variant had characteristic hypofer-
mentemia concerning pancreatospecific enzymes, hyposecretory and
lower obturative types of pancreatic secretion; during sonography
symptoms of significant pancreas fibrosis and disorders of pancreatic
secret outflow were determined: increase of echogeneity, dilation
of Virsung’s duct and calcinates. 34.1% of the patients with
indurative-obstructive CAP variant have a clinical course of the
disease developing as a pseudotumorous pancreatitis. CONCLU-
SION: CAP develops as an indurative-obstructive form in 47.8%
and as a parenchymatous form in 45.5% of the cases. Variants of
the disease should be taken into account when choosing therapeutic
tactics.
20 PROSPECTIVE RANDOMISED COMPARISON OF
ORGAN-PRESERVING PANCREATIC HEAD RESECTION
WITH PYLORUS-PRESERVING
PANCREATODUODENECTOMY
Farkas G, Leindler L, Daro´czi M, Farkas G Jr, Department of
Surgery, University of Szeged, Faculty of Medicine, Szeged,
Hungary
INTRODUCTION AND AIM: In a prospective, randomised,
control trial organ-preserving pancreatic head resection (OPPHR)
was compared with pylorus-preserving pancreatoduodenectomy
(PPPHR) to assess the advantages and disadvantages of each
type of operation. PATIENTS AND METHODS: Forty patients
were allocated randomly to either the OPPHR (n=20) or the
PPPHR (n=20) group. The interval between symptoms and
surgery ranged from 5 to 12 years. The surgical data, postoperative
complications, induction of diabetes mellitus, postoperative pain
and quality of life 6 months postoperatively were considered.
RESULTS: The two study groups of 20 patients were well
balanced with regard to sex, age, chronic pancreatitis history, and
indication for surgery. The duration of the operation for OPPHR
and PPPHR was 142.5+4.9 min and 278+6.9 min, respectively
(p50.001). The postoperative mortality was zero. After OPPHR
and PPPHR, the morbidity was zero and 10%, respectively. The
duration of hospital stay was also significantly different: 8.05+0.9
days vs 13.8+3.9 days (p50.001). After 6 months the pain relief
was effective in both groups, but 3 patients acquired diabetes
mellitus following PPPHR. The body weight increased by
5.8+0.9 kg and 3.2+0.3 kg after OPPHR and PPPHR, respec-
tively (p50.001). CONCLUSION: The two procedures are
equally safe and effective with regard to pain relief but OPPHR is
superior to PPPHR not only in the operation data and morbidity,
but also in the quality of life 6 months postoperatively. OPPHR
should be regarded as a recommended procedure in the treatment
of chronic pancreatitis.
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21 IN VITRO MODEL OF PANCREATIC FIBROSIS:
MATRIGEL AND NAC DEACTIVATE PANCREATIC
STELLATE CELLS
Jesnowski R, Lo¨hr M, Clinical Cooperation Unit Molecular
Gastroenterology, DKFZ, Heidelberg, Germany
INTRODUCTION AND AIM: Background: Progressive fibrosis is
a characteristic feature of chronic pancreatitis. Activated pancreatic
stellate cells (PSCs) are the effector cells for this phenomenon and
the molecular mechanisms leading to PSC activation are currently
under investigation. However, no effective treatment to inhibit
pancreatic fibrosis has been identified up to now. PATIENTS AND
METHODS: Immortalized and activated primary human pancreatic
stellate cells were cultivated on either untreated tissue culture dishes
or on a layer of matrigel with or without 2.5 mM N-acetylcysteine
(NAC) for 3 days. Thereafter the cells in part were fixed and
subsequently stained with Oil Red. In part RNA was isolated from
the cells and reverse transcribed. Subsequently cDNA was amplified
using intron-spanning primers. RESULTS: Incubation of immortal
and primary human activated stellate cells on matrigel plus NAC
treatment resulted in a deactivated phenotype as evidenced by a
decrease of aSMA, CTGF and Col 1 expression and by a decreased
proliferation of the cells. In contrast the treatment resulted in an
upregulation of TIMP2 and MMP2 expression. Moreover during
this treatment the cells regained the ability to store lipids in cyto-
plasmatic vesicles as demonstrated by Oil Red staining. CONCLU-
SION: We were able to demonstrate that besides soluble factors
the matrix surrounding pancreatic stellate cells plays a pivotal role
in the maintenance of the activation status of PSC. Cultivation of
activated PSC on a reconstituted basement membrane plus preven-
tion of oxidative stress by NAC was able to deactivate the cells, thus
pointing to the possibility of an antifibrosis therapy for chronic
pancreatitis.
22 TROPICAL PANCREATITIS – A SINGLE-CENTER
EXPERIENCE
Iype S, Subhalal N, Kuruvilla AP, Surgical Gastroenterology,
Medical College Hospital, Trivandrum, Kerala, India
INTRODUCTION AND AIM: To evaluate various presentations,
surgical management and its outcome in cases presenting with
tropical pancreatitis. PATIENTS AND METHODS: In a retro-
spective analysis of cases admitted to the Department of Surgical
Gastroenterology, Medical College Hospital, Trivandrum (one of
the tertiary level health care centers in Kerala) from January 1993 to
September 2004, there were 327 cases of tropical pancreatitis. It
forms 9.15% of admissions to the department. Median age of clinical
presentation was 34 years (18–65 years). There was a sex predilection
for males (M : F=2.33). Of 327 cases, 189 cases (57.8%) underwent
various surgical procedures. 104 cases (55%) were diagnosed to have
malignancy and 85 cases were benign by various preoperative
investigations. 78% of patients had carcinoma involving head
of pancreas, the rest of them being carcinoma of body and tail of
pancreas. Of 81 carcinomas involving head of pancreas, 32 cases
(39.5%) were resectable and underwent pancreaticoduodenectomy.
In contrast, of 23 cases of carcinoma of body and tail of pancreas only
4 (17.3%) were resectable. Palliative biliary bypass was done in 49
cases of unresectable carcinoma of head of pancreas presented with
obstructive jaundice. 21 cases of unresectable carcinomas underwent
nerve ablation procedures as a palliation for pain. 58% of patients had
diabetes mellitus and the majority of them were controlled with
insulin. Of the benign cases 92% presented with chronic abdominal
pain in the epigastrium radiating to the back and 2 cases presented
with haemosuccus pancreaticus. 71% had main pancreatic duct
dilatation of 412 mm by USS or CT scan. The surgical procedures
for benign disease involved 70 longitudinal pancreatico-jejuno-
stomies (Partington-Rochelle modification of Peustow’s procedure),
9 had distal pancreatectomies with splenectomy, 5 patients under-
went Frey’s procedure and one total pancreatectomy. RESULTS:
Pain relief of satisfactory level was attained in 76% of cases of
benign tropical pancreatitis. Recurrent pain was noticed in 21%
with a latent period ranging from 6 months to 2 years. Incidence
of malignancy among patients who underwent longitudinal
pancreatico-jejunostomy was 12.8% with an average latent period of
5 years (average age of occurrence was 46 years), all of them were
unresectable. Local recurrence of carcinoma after pancreaticoduo-
denectomy was observed in 1 patient, 5 months after first operation.
25% of the patients who underwent biliary bypass alone developed
duodenal obstruction later (within 4 months) and needed gastro-
jejunostomy. Among cases who underwent resection, postoperative
bleeding occurred in 7% , pancreatic leak in 6.2%, delayed gastric
emptying in 16% of pylorus-preserving pancreatoduodenectomies
and 12% had wound infection. Mortality rates were 3.1%, 1.4%, 0%
and 8% for pancreatoduodenectomy, LPJ, distal pancreatectomy
and palliative bypass, respectively. Multifocality of carcinoma in
resected specimen was observed in 9%. The longest survival after
Whipple’s resection is 6 years. Median survivals after resection
were 25 months and 7 months for pancreatoduodenectomies and
distal pancreatecomies, respectively. CONCLUSION: Carcinoma
in tropical pancreatitis has a predilection for head of pancreas.
Multifocal carcinoma occurs only in 9% of cases. Recurrent malig-
nancy after initial resection or bypass is a diagnostic dilemma and the
majority of them are unresectable. Whipple’s resection improves
the survival with an acceptable morbidity and mortality.
23 PANCREATIC FISTULA FOLLOWING PANCREATIC
HEAD RESECTION FOR CHRONIC PANCREATITIS – AN
IMPACT OF THE PROCEDURE?
Schlosser W, Henne-Bruns D, Department of Visceral and
Transplant Surgery, University of Ulm, Ulm, Germany
INTRODUCTION AND AIM: The morbidity following pancreatic
resection could be reduced significantly during the last decade.
However, the morbidity rate even in specialized centers is 40–60%.
The leakage of the pancreatic anastomosis is still the most severe
complication in this type of operation. We report our experience
with the clinical course and management of these complications.
PATIENTS AND METHODS: 456 patients with chronic pan-
creatitis, who were operated between January 1990 and April 2004
with a pancreatic head resection, were analyzed prospectively. The
patients were divided into two groups according to their operative
procedure: pylorus-preserving pancreaticoduodenectomy (PPPD;
n=107 patients) and duodenum-preserving pancreatic head resec-
tion (DPPHR; n=349 patients). Prior to surgery the patients had a
median medical treatment of 41 months (PPPD) and 45 months
(DPPHR), respectively. RESULTS: Hospital mortality was 0.4%
(PPPD 0.9%, DPPHR 0.3%). The morbidity following PPPD was
35% compared to 20% after DPPHR. Local complications were
more frequent after PPPD (26%) compared with DPPHR (15%);
however, the frequency of pancreatic leakage was similar for both
procedures at 5% and 4%, respectively. 7% of the patients operated
with PPPD suffered from delayed gastric emptying in the post-
operative course. There was no difference in the occurrence of
systemic complications (PPPD 8%, DPPHR 5%). Reoperations
were necessary in 6% of the patients, mainly due to bleeding or
septic complications. The median length of hospitalization was
15 days (PPPD) and 14 days, respectively. CONCLUSION: The
mortality for the resection of the pancreatic head for chronic
pancreatitis is 51% in experienced institutions. The frequency of
surgical complications is similar for PPPD and DPPHR, whereas
PPPD is associated with a significantly higher incidence of delayed
gastric emptying. The leakage of the pancreatic anastomosis is similar
for both procedures. Today, pancreatic fistulas can be managed
by drainage in most cases and reoperation is only necessary in
few patients.
24 DUODENUM-PRESERVING PANCREATIC HEAD
RESECTION: BENEFITS AND LIMITATIONS
Beger HG3, Rau B1, Gansauge F2, Poch B2, (1) Surgical
Department, University of Saarland, Saarbru¨cken, Germany; (2)
Visceralsurgery, Illertalclinic, Illertissen, Germany; (3) University
of Ulm, General Surgery, Ulm, Germany
INTRODUCTION AND AIM: Duodenum-preserving pancreatic
head resection (DPPHR) in pancreatic head lesions has the benefit of
an organ-preserving surgical procedure in comparison to the Kausch-
Whipple resection. Indications for duodenum-preserving subtotal/
total pancreatic head resection are: 1. chronic pancreatitis compli-
cated by inflammatory mass in the pancreatic head, stenosis of the
CBD, multiple stenosis and dilations of the PMD, severe narrowing
of the prepapillary duodenum and compression/ stenosis of the
PV/SMV; 2. pancreas divisum causing CP or recurrent acute
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pancreatitis; 3. IPMT in pancreatic head; 4. MCT in pancreatic head
and 5. large endocrine neoplasia in pancreatic head. PATIENTS
AND METHODS: In this video principal surgical steps of the
DPPHR and the modifications (duodenum-preserving total
pancreatic head resection, with segmental peripapillary duodenum
resection) is presented. In the period up to 2004 DPPHR was carried
out in 603 pts with chronic pancreatitis, 36 pts with pancreas divi-
sum, 8 pts with IPMT in pancreatic head, 2 pts with mucinous cystic
tumor in pancreatic head and 3 pts with large endocrine neoplasia
in the pancreatic head resp. uncinate process. The hospital mortality
in patients with chronic pancreatitis was 0.8%, none of the pts with
other indications died. RESULTS: The benefits of DPPHR are
objectified by preservation of the stomach, duodenum and biliary tree
as well as maintenance of the endocrine pancreatic functions in spite
of pancreatic head resection. Patients suffering IPMT and MCT
lesions in the pancreatic head should have a total duodenum
pancreatic head resection, in some patients including segmental
resection of the peripapillary duodenum to achieve complete removal
of the lesion. In patients with an IPMT and advanced cancer a radical
oncological resection is mandatory.
25 RELEVANCE OF IgG4 AND ANTIBODIES
TO CARBONIC ANHYDRASE II FOR DIAGNOSIS OF
AUTOIMMUNE CHRONIC PANCREATITIS IN A
MULTICENTER STUDY
Sastre J1, Aparisi L14, Farre´ A2, Go´mez-Cambronero L3,
Martı´nez J4, De las Heras G5, Corts J6, Navarro S7, Mora J8,
Lo´pez-Hoyos M9, Sabater L10, Ferra´ndez A11, Bautista D12,
Pe´rez-Mateo M4, Soledad M13, (1) Department of Physiology,
University of Valencia; (2) Service of Gastroenterology, Santa Creu
and Sant Pau Hospital, Barcelona; (3) Department of Physiology,
University of Valencia; (4) Department of Gastroenterology,
University General Hospital, Alicante; (5) Department of
Gastroenterology, Marque´s de Valdecilla Hospital, Santander; (6)
Department of Reumathology, Universitary Clinic Hospital,
Valencia; (7) Department of Gastroenterology, Hospital Clinic,
Barcelona; (8) Department of Biochemistry, Santa Creu and Sant
Pau Hospital, Barcelona; (9) Department of Immunology, Marque´s
de Valdecilla Hospital, Santander; (10) Department of Surgery,
Universitary Clinic Hospital, Valencia, (11) Department of
Pathology, University of Valencia; (12) Department of Preventive
Medicine, Hospital Dr Peset, Valencia; (13) Department of
Biochemistry, Universitary Clinic Hospital, Valencia; (14)
Universitary Clinic Hospital, Department of Hepatology, Valencia,
Spain
INTRODUCTION AND AIM: Increased serum antibodies to
carbonic anhydrase II (CA-IIAb) or IgG4 levels have been reported
in cases of autoimmune chronic pancreatitis (ACP). Our aim was
to assess the relevance of increased serum CA-IIAb and IgG4
levels for the diagnosis of ACP in idiopathic CP (ICP) versus
alcoholic CP and Sjo¨gren’s syndrome (SS). PATIENTS AND
METHODS: This multicenter study involved five hospitals and 227
subjects classified in 4 groups: ICP (n=54); normal controls (n=54,
paired by age and sex with ICP patients); alcoholic CP (n=86); and
SS (n=33). CA-IIAb was measured by ELISA. IgG4 serum levels
were measured by nephelometry, and IgG4 immunohistochemistry
was performed in surgical specimens. A score based on the major
clinical, morphological and biochemical parameters for diagnosis
of ACP was applied. RESULTS: The percentage of patients with
elevated IgG4 levels was higher in the ICP group (15%) vs controls
(1.9%) and SS (0%), but not significantly different from alcoholic
CP (8%). The proportion with increased serum CA-IIAb was higher
in the ICP group (28%) than in controls (1.9%) and in patients with
alcoholic CP (10.5%), but lower than in patients with SS (64%).
Most ICP patients (7/8) with high IgG4 levels exhibited increased
CA-IIAb and a compatible ACP score. A definitive diagnosis of
ACP by histological analysis was associated with other autoimmune
disorders, an increase in both serum IgG4 and CA-IIAb levels and
IgG4-positive plasma cells. CONCLUSION: In conclusion, the
increase in serum IgG4 levels was strongly associated with elevated
CA-IIAb levels, manifestations compatible with ACP, and lympho-
plasmacytic infiltration.
26 USING FECAL ELASTASE-1 TO SCREEN FOR
CHRONICITY IN PATIENTS ADMITTED WITH ACUTE
PANCREATITIS
Turner RC2, McDermott R1, (1) Division of Health Sciences,
University of South Australia; (2) James Cook University,
Department of Surgery, Cairns, Australia
INTRODUCTION AND AIM: Patients presenting with acute
pancreatitis may have co-existing chronic pancreatitis, the accurate
diagnosis of which would potentially guide appropriate management.
Gold standard tests are often invasive, costly or time-consuming, but
the fecal elastase-1 assay has been shown to be comparatively accu-
rate for moderate and severe exocrine deficiency. This study aimed
to evaluate fecal elastase-1 concentration [FE-1] against clinical
criteria for chronicity in an acute setting. PATIENTS AND
METHODS: [FE-1] was performed on patients admitted with acute
onset of epigastric pain and a serum lipase at least twice the upper
limit of normal. Likely chronic disease was defined by the presence
of specific clinical, pathological or radiological criteria. A 2r2
table comparing [FE-1] and clinical diagnosis was constructed.
RESULTS: 117 stool specimens from 95 patients were suitable for
[FE-1] determination. Values were compared to clinical criteria
of chronicity, after exclusion of liquid stool specimens and cases of
moderate or severe acute pancreatitis (Ranson’s score42). Using an
exocrine insufficiency threshold of 200 mcg/g, [FE-1] yielded the
following results as a screening tool for chronic pancreatitis: positive
predictive value, 96.9%; negative predictive value, 86.0%; sensitivity,
79.5%; specificity, 98.0%. CONCLUSION: [FE-1] is an accurate
screening tool for chronic exocrine insufficiency when taken in the
course of a hospital admission for mild acute pancreatitis.
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